双能CT在胰腺疾病中的应用进展
本文综述双能CT在胰腺疾病(包括胰腺炎、胰腺癌、胰腺囊性肿瘤、胰腺神经内分泌肿瘤及胰腺损伤)诊断、生物学特征描述和生存预测中的应用,并总结其当前局限性与未来研究前景。双能CT可定量提取和分析医学影像特征,并建立这些特征与临床结果之间的关联,从而为胰腺疾病患者采取更现代、更准确的临床诊疗策略,以实现无创、低成本、个体化治疗的目标。
要点
- 双能CT可定量提取影像特征并关联临床结果,用于胰腺疾病的无创诊断与个体化诊疗。
- 综述涵盖胰腺炎、胰腺癌、胰腺囊性肿瘤、胰腺神经内分泌肿瘤及胰腺损伤。
- 双能CT的应用包括诊断、生物学特征描述和患者生存预测。
核心结论
- 双能CT在胰腺疾病的诊断、生物学特征描述和生存预测中有应用价值,但存在当前局限性并有待未来研究。
研究设计与样本
- 综述,阐述双能CT在胰腺疾病中的应用并总结其当前局限性与未来研究前景。
局限性
- 原文总结了双能CT当前的局限性,但摘要未具体列出。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pancreatic diseases are difficult to diagnose due to their insidious onset and complex pathophysiological developmental characteristics. In recent years, dual-energy computed tomography (DECT) imaging technology has rapidly advanced. DECT can quantitatively extract and analyze medical imaging features and establish a correlation between these features and clinical results. This feature enables the adoption of more modern and accurate clinical diagnosis and treatment strategies for patients with pancreatic diseases so as to achieve the goal of non-invasive, low-cost, and personalized treatment. The purpose of this review is to elaborate on the application of DECT for the diagnosis, biological characterization, and prediction of the survival of patients with pancreatic diseases (including pancreatitis, pancreatic cancer, pancreatic cystic tumor, pancreatic neuroendocrine tumor, and pancreatic injury) and to summarize its current limitations and future research prospects.
引用
- Wang S, Zhang Y, Xu Y, et al. Progress in the application of dual-energy CT in pancreatic diseases. Eur J Radiol. 2023. PMID: 37742372. doi:10.1016/j.ejrad.2023.111090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。